Donna Culton, MD, University of North Carolina at Chapel Hill, outlines diagnosing autoimmune blistering diseases.
Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027Data from the ongoing parallel BROADEN2 Phase 2b atopic ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATE ...
Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals. In this module, you will master the immunopathology of bullous pemphigoid (BP) and its disease burden. In ...
The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...
Hosted on MSN
What if your skin could warn you about disease before symptoms appear by glowing green?
Scientists have created living skin that lights up bright green when inflammation rises inside the body. The engineered tissue, about the size of a quarter, works like a biological smoke detector, and ...
The DWP has issued a full list of 533 conditions which could qualify you for a £187 a week payment. Personal Independence ...
While skin conditions are often visible, their burden can extend far beyond the skin. At any given time, almost one in three people struggle with recurrent skin problems, affecting individuals of all ...
PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results